SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 18 | -87.3% | 0.00% | – |
| Q2 2022 | $4,000 | +100.0% | 142 | +71.1% | 0.00% | – |
| Q1 2022 | $2,000 | -77.8% | 83 | -74.9% | 0.00% | – |
| Q4 2021 | $9,000 | +50.0% | 331 | +5.1% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 315 | +25.5% | 0.00% | – |
| Q2 2020 | $6,000 | -25.0% | 251 | -44.6% | 0.00% | – |
| Q1 2020 | $8,000 | +166.7% | 453 | +248.5% | 0.00% | – |
| Q4 2019 | $3,000 | -91.7% | 130 | -89.9% | 0.00% | – |
| Q3 2019 | $36,000 | -18.2% | 1,293 | -2.3% | 0.00% | -100.0% |
| Q2 2019 | $44,000 | +15.8% | 1,323 | +22.3% | 0.00% | 0.0% |
| Q1 2019 | $38,000 | +245.5% | 1,082 | +232.9% | 0.00% | – |
| Q4 2018 | $11,000 | -31.2% | 325 | 0.0% | 0.00% | – |
| Q3 2018 | $16,000 | -15.8% | 325 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | – | 325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |